Pradžia › Ūmi bifeninė leukemija › Washington › Seattle

Ūmi bifeninė leukemija klinikiniai tyrimai Seattle, WA

15 tyrimai dėl Ūmi bifeninė leukemija ieško dalyvių vietose Seattle ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Renkami dalyviai1 fazė

Fred Hutchinson Cancer Center, Seattle

Amžius nuo 12 iki 78 · Visoms lytims · Atnaujinta 2026-09-29 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Renkami dalyviai2 fazė

Seattle Children's Hospital, Seattle

365 Days · Visoms lytims · Atnaujinta 2026-09-25 · NCT06317662

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Renkami dalyviai1 fazė

Fred Hutch/University of Washington Cancer Consortium, Seattle

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT04375631

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

Renkami dalyviai

Fred Hutch/University of Washington Cancer Consortium, Seattle

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT07094750

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Renkami dalyviai3 fazė

Seattle Children's Hospital, Seattle

365 Days – 25 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Renkami dalyviai1/2 fazė

Seattle Children's Hospital, Seattle

Iki 22 metų · Visoms lytims · Atnaujinta 2026-08-25 · NCT04726241

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Renkami dalyviai2 fazė

Fred Hutch/University of Washington Cancer Consortium, Seattle

6 Months – 65 Years · Visoms lytims · Atnaujinta 2026-07-22 · NCT06013423

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

Renkami dalyviai2 fazė

Fred Hutch/University of Washington Cancer Consortium, Seattle

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-20 · NCT07046078

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Renkami dalyviai1/2 fazė

Fred Hutch/University of Washington Cancer Consortium, Seattle

Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-06-22 · NCT03128034

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Renkami dalyviai1/2 fazė

Fred Hutch/University of Washington Cancer Consortium, Seattle

Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-06-22 · NCT03670966

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Renkami dalyviai2 fazėLaukiami sveiki savanoriai

Fred Hutch/University of Washington Cancer Consortium, Seattle

6 Months · Visoms lytims · Atnaujinta 2026-05-29 · NCT04195633

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Renkami dalyviai1 fazė

Fred Hutch/University of Washington Cancer Consortium, Seattle

Iki 80 metų · Visoms lytims · Atnaujinta 2026-05-18 · NCT03326921

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai

Fred Hutch/University of Washington Cancer Consortium, Seattle

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-15 · NCT06928662

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Renkami dalyviai1/2 fazė

Fred Hutch/University of Washington Cancer Consortium, Seattle

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-17 · NCT04797767

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Renkami dalyviai1 fazė

Seattle Children's Hospital, Seattle

Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2024-12-06 · NCT05476770

Ūmi bifeninė leukemija tyrimai kituose miestuose

Kiti tyrimai Seattle

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.